BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 9464204)

  • 1. Remission of substance use disorder among psychiatric inpatients with mental illness.
    Dixon L; McNary S; Lehman AF
    Am J Psychiatry; 1998 Feb; 155(2):239-43. PubMed ID: 9464204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.
    Swartz MS; Swanson JW; Hiday VA; Borum R; Wagner HR; Burns BJ
    Am J Psychiatry; 1998 Feb; 155(2):226-31. PubMed ID: 9464202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5 years.
    Culverhouse R; Bucholz KK; Crowe RR; Hesselbrock V; Nurnberger JI; Porjesz B; Schuckit MA; Reich T; Bierut LJ
    Arch Gen Psychiatry; 2005 Jul; 62(7):753-60. PubMed ID: 15997016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of secondary versus primary mental disorder in persons with comorbid substance use disorders.
    Dixon L; McNary S; Lehman A
    Am J Psychiatry; 1997 Nov; 154(11):1610-2. PubMed ID: 9356576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of substance use disorders among psychiatric inpatients.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    J Nerv Ment Dis; 1996 Apr; 184(4):228-33. PubMed ID: 8604032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse and family relationships of persons with severe mental illness.
    Dixon L; McNary S; Lehman A
    Am J Psychiatry; 1995 Mar; 152(3):456-8. PubMed ID: 7864278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of substance use disorders among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson J
    J Nerv Ment Dis; 1994 Mar; 182(3):164-7. PubMed ID: 8113777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment.
    Colpaert K; De Maeyer J; Broekaert E; Vanderplasschen W
    Eur Addict Res; 2013; 19(4):173-83. PubMed ID: 23257413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Arab and Jewish patients admitted for psychiatric hospitalization in Jerusalem: the demographic, psychopathologic aspects, and the drug abuse comorbidity.
    Katz G; Grunhaus L; Deeb S; Shufman E; Bar-Hamburger R; Durst R
    Compr Psychiatry; 2012 Aug; 53(6):850-3. PubMed ID: 22197215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axis II comorbidity in substance abusers.
    Nace EP; Davis CW; Gaspari JP
    Am J Psychiatry; 1991 Jan; 148(1):118-20. PubMed ID: 1984695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of measures used to determine substance abuse in an inpatient psychiatric population.
    Albanese MJ; Bartel RL; Bruno RF; Morgenbesser MW; Schatzberg AF
    Am J Psychiatry; 1994 Jul; 151(7):1077-8. PubMed ID: 8010367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.